Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.71 - $10.1 $270,825 - $580,750
57,500 Added 563.73%
67,700 $378 Million
Q2 2024

Aug 14, 2024

SELL
$7.96 - $13.59 $111,440 - $190,260
-14,000 Reduced 57.85%
10,200 $85.9 Million
Q1 2024

May 15, 2024

SELL
$13.56 - $20.78 $24,408 - $37,404
-1,800 Reduced 6.92%
24,200 $349 Million
Q4 2023

Feb 14, 2024

BUY
$14.18 - $22.31 $368,680 - $580,060
26,000 New
26,000 $560 Million

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $160M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Crawford Fund Management, LLC Portfolio

Follow Crawford Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crawford Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crawford Fund Management, LLC with notifications on news.